476
Views
3
CrossRef citations to date
0
Altmetric
Letters

Nephrotoxic synergism of cisplatin and mitomycin-C for hyperthermic intraperitoneal chemotherapy and cytoreductive surgery

, &
Page 601 | Received 20 Mar 2018, Accepted 26 Mar 2018, Published online: 25 Jun 2018

References

  • Tan GHC, Shannon NB, Chia CS, et al. Platinum agents and mitomycin C-specific complications in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Int Journal of Hyperthermia. 2017;1–6. doi:10.1080/02656736.2017.1345014
  • Passcot G, Bakrin N, Isaac S, et al. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol. 2014;40:957–962.
  • Esquivel J, Averbach A, Chua TC. Laparoscopic cytoreductive suirgery and hyperthermic intraperitoneal chemotherapy in patients with limited peritoneal surface malignancies: feasibility, morbidity, and outcome in an early experience. Ann Surg. 2011;253:764–768.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.